Being an Oncology Hospitalist

Chen, Eddy J.

doi:10.1016/j.ehmc.2016.02.002

Cited by 3 publications

(3 citation statements)

References 31 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These include limited staffing, an increasing number of patients with cancer, regulation of resident work hours, research, clinic, and medical education requirements for oncologists, and advances in cancer treatment that extend lives but result in more complex hospital admissions. 4 Previous research in this area has demonstrated that compared with a traditional care model where oncology floors are staffed by rotating outpatient oncologists (Outpt ONC), hospitalist-led teams caring for oncology patients provide comparable care, 5,6 with some studies demonstrating shorter LOS, 7 lower inpatient mortality, 8 and increased discharges to hospice but increased 30-day readmission rates. 9 A survey of oncologists at a tertiary care center showed that a minority felt that attending on the inpatient service was an efficient use of their time and most felt that hospitalists could appropriately diagnose and manage toxicities related to cancer and cancer treatment.…”

Section: Introductionmentioning

confidence: 99%

“…3 Oncology patients are a unique population with a high rate of hospitalizations and readmissions. 4 Some hospitals have begun using the hospitalist model on inpatient oncology floors for a variety of reasons. These include limited staffing, an increasing number of patients with cancer, regulation of resident work hours, research, clinic, and medical education requirements for oncologists, and advances in cancer treatment that extend lives but result in more complex hospital admissions.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Objective Impact of Hematology-Oncology Hospitalist Care in an Inpatient Setting

Fanucci

Yang

Chambers

et al. 2022

JCO Oncology Practice

View full text Add to dashboard Cite

PURPOSE: The utilization of the hospitalist care model has increased over the past decade because of improved cost-effectiveness, quality of care, and value that it provides. Studies have shown that compared with the traditional care model, use of hospitalists provides cost-saving and improved value to hospital systems. However, the data for the use of oncology hospitalists (ONC Hosp) are sparse. In this study, we investigate the impact of inpatient ONC Hosp on 30-day readmissions, length of stay (LOS), discharge to hospice, and inpatient mortality when compared with a traditional model where outpatient oncologists manage the acute issues of hospitalized patients with cancer. METHODS: Rhode Island Hospital hired ONC Hosps to attend on the inpatient oncology service. To determine the impact of this new patient care model, we performed a retrospective review of oncology patients admitted to Rhode Island Hospital between July 1, 2012, and June 30, 2018, and compared quality outcomes of 30-day readmission, LOS, discharge to hospice, and inpatient mortality to those from the traditional care model. RESULTS: Compared with outpatient oncologists care, care by ONC Hosp was associated with a significant decrease in 30-day readmissions (23.0% v 29.6%, P = .019) and a significant increase in discharge to hospice (18.1% v 12.1%, P < .001). No significant difference was detected between LOS ( P = .833) or inpatient mortality ( P = .332). CONCLUSION: This study shows that compared with the traditional care model, the use of ONC Hosps has a positive impact on patient care and the potential to add value to the hospital system.

show abstract

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Objective Impact of Hematology-Oncology Hospitalist Care in an Inpatient Setting

Fanucci

Yang

Chambers

et al. 2022

JCO Oncology Practice

View full text Add to dashboard Cite

show abstract

“…With the increasing incidence of irAEs requiring hospitalization, oncology-hospitalists (physicians specialized in inpatient cancer care) 16 are at the forefront of irAE management. Clinical care pathways rooted in evidence-based knowledge enhance teamwork, standardize practices, streamline care processes, and reduce burnout risk in acute hospital settings 17,18 . While professional oncology organizations offer guidelines for irAE management, none provide a comprehensive care pathway from presentation to follow-up after hospitalization 10,14,19,20 .…”

Section: Introductionmentioning

confidence: 99%

Optimizing Inpatient Care for Lung Cancer Patients with Immune Checkpoint Inhibitor- Related Pneumonitis Using a Clinical Care Pathway Algorithm

Brito-Dellan,

Franco-Vega,

Ruiz

et al. 2024

Preprint

View full text Add to dashboard Cite

Purpose Immune checkpoint inhibitor-related pneumonitis (ICI-P) is a condition associated with high mortality, necessitating prompt recognition and treatment initiation. This study aimed to assess the impact of implementing a clinical care pathway algorithm on reducing the time to treatment for ICI-P. Methods Patients with lung cancer and suspected ICI-P were enrolled, and a multi-modal intervention promoting algorithm use was implemented in two phases. Pre- and post-intervention analyses were conducted to evaluate the primary outcome of time from ICI-P diagnosis to treatment initiation. Results Of the 82 patients admitted with suspected ICI-P, 73.17% were confirmed to have ICI-P, predominantly associated with non-small cell lung cancer (91.67%) and stage IV disease (95%). Pembrolizumab was the most commonly used immune checkpoint inhibitor (55%). The mean times to treatment were 2.37 days in the pre-intervention phase and, 3.07 days (p=0.46), and 1.27 days (p=0.40) in the post-intervention phases 1 and 2, respectively. Utilization of the immunotoxicity order set significantly increased from 0% to 27.27% (p = 0.04) after phase 2. While there were no significant changes in ICU admissions or inpatient mortality, outpatient pulmonology follow-ups increased statistically significantly, demonstrating enhanced continuity of care. The overall mortality for patients with ICI-P was 22%, underscoring the urgency of optimizing management strategies. Notably, all patients discharged on high-dose corticosteroids received appropriate gastrointestinal prophylaxis and prophylaxis against Pneumocystis jirovecii pneumonia infections at the end of phase 2. Conclusion Implementing a clinical care pathway algorithm for ICI-P management standardizes care practices and enhances patient outcomes, underscoring the importance of structured approaches.

show abstract

Optimizing inpatient care for lung cancer patients with immune checkpoint inhibitor-related pneumonitis using a clinical care pathway algorithm

Brito-Dellan,

Franco-Vega,

Ruiz

et al. 2024

Support Care Cancer

View full text Add to dashboard Cite

Being an Oncology Hospitalist

Cited by 3 publications

References 31 publications

Objective Impact of Hematology-Oncology Hospitalist Care in an Inpatient Setting

Objective Impact of Hematology-Oncology Hospitalist Care in an Inpatient Setting

Optimizing Inpatient Care for Lung Cancer Patients with Immune Checkpoint Inhibitor- Related Pneumonitis Using a Clinical Care Pathway Algorithm

Optimizing inpatient care for lung cancer patients with immune checkpoint inhibitor-related pneumonitis using a clinical care pathway algorithm

Contact Info

Product

Resources

About